Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.

Quotes for Abera Bioscience AB

Right Now

+/-
0.25
%
1,39%
Latest
18.2
High
19
Low
17.7
Volume
32 524
Turnover (SEK)
588 000
Value (MSEK)
190,4

Board

CEO

  • Maria Alriksson

Chairperson of the Board

  • Anders Ericsson

Board

  • Cristina Glad
  • Fredrik Juserius
  • Joen Luirink

Videos

Largest Owners

Name Capital % Votes % Date
Nordnet Pensionsförsäkring 10,62 10,62 2021-09-30
Avanza Pension 10,54 10,54 2021-09-30
Anders Ericsson 6,66 6,66 2021-02-08
Magnus Linderoth 5,89 5,89 2021-09-30
Jan-Willem De Gier 5,71 5,71 2021-09-30
Joen Luirink 5,58 5,58 2021-09-30
John Moll 4,90 4,90 2021-02-08
Johan Källstrand 3,89 3,89 2021-09-30
Anders Wall Stiftelser 3,06 3,06 2021-09-30
Maria Alrikson 2,48 2,48 2021-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2021-11-10 Delårsrapport 2021-Q3

  • 2022-02-23 Bokslutskommuniké 2021